Works about THIAZOLIDINEDIONES
Results: 801
What is the role of pioglitazone for patients with type 2 diabetes in value-based care settings?
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 3, p. 131, doi. 10.1007/s40267-024-01052-1
- By:
- Publication type:
- Article
Enantioselective and Chemoselective Phosphine Oxide‐catalyzed Aldol Reactions of N‐Unprotected Cyclic Carboxyimides.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 15, p. 1, doi. 10.1002/chem.202203506
- By:
- Publication type:
- Article
Preventing progression from gestational diabetes mellitus to diabetes: A thought-filled review.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Stimulation of ENaC activity by rosiglitazone is PPARγ-dependent and correlates with SGK1 expression increase.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Risk of Stroke with Thiazolidinediones: A Ten-Year Nationwide Population-Based Cohort Study.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 145, doi. 10.1159/000353679
- By:
- Publication type:
- Article
The Capsular Warning Syndrome Reconsidered.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 152, doi. 10.1159/000352045
- By:
- Publication type:
- Article
Hypertrophic Olivary Degeneration after Pontine Hemorrhage: A Cause of Delayed Neurological Deterioration.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 153, doi. 10.1159/000352063
- By:
- Publication type:
- Article
Rapid Progression of Unilateral Moyamoya Disease in a Patient with a Family History and an RNF213 Risk Variant.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 155, doi. 10.1159/000352065
- By:
- Publication type:
- Article
Reversible Cerebral Vasoconstriction Syndrome after Chewing Khat Leaves.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 158, doi. 10.1159/000353664
- By:
- Publication type:
- Article
ESO News.
- Published in:
- Cerebrovascular Diseases, 2013, v. 36, n. 2, p. 160, doi. 10.1159/000355578
- By:
- Publication type:
- Article
Synthesis and Evaluation of the Hypoglycemic and Hypolipidemic Activity of Novel Arylidene Thiazolidinedione Analogson a Type 2 Diabetes Model.
- Published in:
- Pharmaceutical Chemistry Journal, 2016, v. 50, n. 3, p. 165, doi. 10.1007/s11094-016-1416-z
- By:
- Publication type:
- Article
Synthesis and antimicrobial activity of [6′-methyl-4′-methoxy-2-oxo-2H-[1]-benzopyran)-2″,4″-dihydro-[1″, 2″, 4″]-triazol-3″-one and 3″-phenyl-thiazolidin-4″-one-phenoxymethyl derivatives of dipyranoquinoline
- Published in:
- Pharmaceutical Chemistry Journal, 2011, v. 45, n. 7, p. 427, doi. 10.1007/s11094-011-0648-1
- By:
- Publication type:
- Article
Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 18, p. 1411, doi. 10.1093/jnci/djs328
- By:
- Publication type:
- Article
Illuminating the Diabetes–Cancer Link.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 14, p. 1048, doi. 10.1093/jnci/djs322
- By:
- Publication type:
- Article
Synthesis and in vitro antiproliferative and antibacterial activity of new thiazolidine-2,4-dione derivatives.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2018, v. 33, n. 1, p. 17, doi. 10.1080/14756366.2017.1387543
- By:
- Publication type:
- Article
Synthesis of new Schiff bases bearing 1,2,4-triazole, thiazolidine and chloroazetidine moieties and their pharmacological evaluation.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2017, v. 32, n. 1, p. 119, doi. 10.1080/14756366.2016.1238365
- By:
- Publication type:
- Article
Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo[d]thiazol -2-yl)thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2013, v. 28, n. 1, p. 113, doi. 10.3109/14756366.2011.636362
- By:
- Publication type:
- Article
HOW TO MANAGE DIABETES DURING RAMADAN (UPDATED JANUARY 2022).
- Published in:
- Diabetes & Primary Care, 2022, v. 24, n. 1, p. 9
- By:
- Publication type:
- Article
A disease state approach to the pharmacological management of Type 2 diabetes in primary care: A position statement by Primary Care Diabetes Europe.
- Published in:
- Diabetes & Primary Care, 2020, v. 22, n. 3, p. 1
- By:
- Publication type:
- Article
The SIGN 154 diabetes guideline and primary care: it's not just about the glucose.
- Published in:
- Diabetes & Primary Care, 2018, v. 20, n. 2, p. 75
- By:
- Publication type:
- Article
Diabetes and bone health.
- Published in:
- Diabetes & Primary Care, 2016, v. 18, n. 2, p. 68
- By:
- Publication type:
- Article
Hyperglycaemia in type 2 diabetes: Older blood glucose-lowering therapies — update.
- Published in:
- Diabetes & Primary Care, 2012, v. 14, n. 1, p. 35
- By:
- Publication type:
- Article
Do oral antidiabetic medications alter the risk of Parkinson's disease? An updated systematic review and meta-analysis.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 12, p. 4193, doi. 10.1007/s10072-023-06965-9
- By:
- Publication type:
- Article
Falsification Testing of Instrumental Variables Methods for Comparative Effectiveness Research.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Effect of Tianmai Xiaoke Pian on Insulin Resistance through PI3-K/AKT Signal Pathway.
- Published in:
- Journal of Diabetes Research, 2015, p. 1, doi. 10.1155/2016/9261259
- By:
- Publication type:
- Article
Crosstalk between PPARγ Ligands and Inflammatory-Related Pathways in Natural T-Regulatory Cells from Type 1 Diabetes Mouse Model.
- Published in:
- Biomolecules (2218-273X), 2018, v. 8, n. 4, p. 135, doi. 10.3390/biom8040135
- By:
- Publication type:
- Article
DPP-4 Inhibitors as a New Option for the Management of Type 2 Diabetes.
- Published in:
- Journal of Korean Diabetes, 2013, v. 14, n. 3, p. 128, doi. 10.4093/jkd.2013.14.3.128
- By:
- Publication type:
- Article
Glucose‐lowering drugs and liver‐related outcomes among individuals with type 2 diabetes: A systematic review of longitudinal population‐based studies.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 11, p. 1, doi. 10.1111/dme.15437
- By:
- Publication type:
- Article
Five comparative cohorts to assess the risk of genital tract infections associated with sodium‐glucose cotransporter‐2 inhibitors initiation in type 2 diabetes mellitus.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 8, p. 1, doi. 10.1111/dme.14858
- By:
- Publication type:
- Article
More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.
- Published in:
- Diabetic Medicine, 2020, v. 37, n. 2, p. 194, doi. 10.1111/dme.14179
- By:
- Publication type:
- Article
Treatment of heart failure with sodium glucose co‐transporter‐2 inhibitors in people with type 2 diabetes mellitus: current evidence and future directions.
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 12, p. 1550, doi. 10.1111/dme.14140
- By:
- Publication type:
- Article
Long‐term comparative safety analysis of the risks associated with adding or switching to a sulfonylurea as second‐line Type 2 diabetes mellitus treatment in a US veteran population.
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 11, p. 1384, doi. 10.1111/dme.13839
- By:
- Publication type:
- Article
Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti‐hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2019, v. 36, n. 4, p. 491, doi. 10.1111/dme.13835
- By:
- Publication type:
- Article
Cardiovascular events associated with second-line anti-diabetes treatments: analysis of real-world Korean data.
- Published in:
- Diabetic Medicine, 2017, v. 34, n. 9, p. 1235, doi. 10.1111/dme.13384
- By:
- Publication type:
- Article
Plasma neutrophil gelatinase-associated lipocalin levels are positively associated with diabetic retinopathy in patients with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 12, p. 1649, doi. 10.1111/dme.13141
- By:
- Publication type:
- Article
Guidelines for managing diabetes in Ramadan.
- Published in:
- Diabetic Medicine, 2016, v. 33, n. 10, p. 1315, doi. 10.1111/dme.13080
- By:
- Publication type:
- Article
The effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo.
- Published in:
- Diabetic Medicine, 2015, v. 32, n. 5, p. 657, doi. 10.1111/dme.12664
- By:
- Publication type:
- Article
Clinical predictors and time course of the improvement in β-cell function with short-term intensive insulin therapy in patients with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2015, v. 32, n. 5, p. 645, doi. 10.1111/dme.12671
- By:
- Publication type:
- Article
Residual effect of reductions in red blood cell count and haematocrit and haemoglobin levels after 10-month withdrawal of pioglitazone in patients with Type 2 diabetes.
- Published in:
- Diabetic Medicine, 2014, v. 31, n. 11, p. 1341, doi. 10.1111/dme.12481
- By:
- Publication type:
- Article
A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.00752
- By:
- Publication type:
- Article
Insulin resistance in chronic kidney disease.
- Published in:
- Nephrology, 2017, v. 22, p. 31, doi. 10.1111/nep.13147
- By:
- Publication type:
- Article
ESTIMATION OF PEROXISOME PROLIFERATORS - ACTIVATED RECEPTOR γ GENE EXPRESSION IN INFLAMMATORY SKIN DISEASES: ATOPIC DERMATITIS AND PSORIASIS.
- Published in:
- Our Dermatology Online / Nasza Dermatologia Online, 2014, v. 5, n. 2, p. 107, doi. 10.7241/ourd.20142.27
- By:
- Publication type:
- Article
Lack of pharmacokinetic interaction for ISIS 113715, a 2'-0-methoxyethyl modified antisense oligonucleotide targeting protein tyrosine phosphatase 1B messenger RNA, with oral antidiabetic compounds metformin, glipizide or rosiglitazone.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Microbial Targets Can Help Make Parkinson's History.
- Published in:
- BioScience, 2017, v. 67, n. 5, p. 484, doi. 10.1093/biosci/bix032
- By:
- Publication type:
- Article
Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.1010485
- By:
- Publication type:
- Article
In Silico Identification Of A Potentially Novel Binding Modality For 1,3-Dicarbonyl Compounds Having 2(3H)-Benzazolonic Heterocycles Within The PPARγ Ligand Binding Pocket: A De Novo Design Study.
- Published in:
- Biomirror, 2014, v. 5, n. 1, p. 1
- By:
- Publication type:
- Article
Diabetes mellitus: Exploring the challenges in the drug development process.
- Published in:
- Perspectives in Clinical Research, 2012, v. 3, n. 3, p. 109, doi. 10.4103/2229-3485.100660
- By:
- Publication type:
- Article
Thiazolidinediones: Understanding their role in diabetes management.
- Published in:
- African Journal of Diabetes Medicine, 2024, v. 32, n. 3, p. 9, doi. 10.54931/AJDM-32.3.4
- By:
- Publication type:
- Article
Glucose‐lowering action through targeting islet dysfunction in type 2 diabetes: Focus on dipeptidyl peptidase‐4 inhibition.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 7, p. 1128, doi. 10.1111/jdi.13564
- By:
- Publication type:
- Article
Biphasic insulin aspart‐30 reduces glycemic variability to a greater degree than insulin detemir: A randomized controlled trial of once‐daily insulin regimens using continuous glucose monitoring.
- Published in:
- Journal of Diabetes Investigation, 2018, v. 9, n. 3, p. 573, doi. 10.1111/jdi.12747
- By:
- Publication type:
- Article